Clinical Trial

Walking Sensation Study

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this new line of research is to test whether augmenting sensory information from the legs, using Walkasins sensory neuroprosthesis, can enhance performance of a complex walking task in older adults with foot sensory impairment. The overarching hypothesis is that Walkasins will enhance the automaticity and reduce cognitive demand of walking in older adults with foot sensory impairments, as measured by reduced prefrontal activity, decreased dual-task costs, and lower gait variability.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-05-07; most recent amendment 2026-06-02.
Status change: Not Yet Recruiting → Recruiting 2025-09-29
Trial Details
NCT Number NCT06975423
Lead Sponsor University of Florida
Collaborators: The Claude D. Pepper Older Americans Independence Centers, National Institute on Aging (NIA)
Conditions Aging, Sensory Deficit
Enrollment 30 participants
Start Date 2025-09-08
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-04